Although the effect of the single nucleotide polymorphism (SNP) associated with PSP is unknown, it is noteworthy that the interaction of calcineurin with PERK promotes PERK auto-phosphorylation, leading to translation inhibition (Bollo et al., 2010). The gene discussed is EIF2AK3; the disease is supranuclear palsy, progressive, 1.